Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells

Experimental Hematology

Volumn 31, Issue 6, 2003, Pages 551-558

  Shultz, Leonard D ^a   Banuelos, Scott J ^b   Leif, Jean ^b   Appel, Michael C ^b   Cunningham, Melody ^c   Ballen, Karen ^b   Burzenski, Lisa ^a   Greiner, Dale L ^b  

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CELL ANTIBODY; INTERLEUKIN 2 RECEPTOR BETA; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD CELL; BONE MARROW CELL; CELL ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; GENE DELETION; GENETIC MANIPULATION; HEMATOPOIESIS; HOST CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; UMBILICAL CORD BLOOD;

MURINAE;

EID: 0038725903     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00076-6     Document Type: Conference Paper

References (34)

1. Greiner D.L., Hesselton R.A., Shultz L.D. SCID mouse models of human stem cell engraftment. Stem Cells. 16:1998;166-177.
2. Greiner D.L., Shultz L.D. Use of NOD/LtSz-scid/scid mice in biomedical research. Leiter E.H., Atkinson M.A. NOD Mice and Related Strains: Research Applications in Diabetes, AIDS, Cancer, and Other Diseases. 1998;173-204 R.G. Landes Co, Austin, TX.
3. Christianson S.W., Greiner D.L., Schweitzer I.B., et al. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. Cell Immunol. 171:1996;186-199.
4. Leiter E. Genetics and immunogenetics of NOD mice and related strains. Leiter E.H., Atkinson M.A. NOD Mice and Related Strains: Research Applications in Diabetes AIDS. Cancer, and Other Diseases. 1998;37-69 R.G. Landes Co, Austin, TX.
5. Dick J.E. Normal and leukemic human stem cells assayed in SCID mice. Semin Immunol. 8:1996;197-206.
6. Woods N.B., Ooka A., Karlsson S. Development of gene therapy for hematopoietic stem cells using lentiviral vectors. Leukemia. 16:2002;563-569.
7. + cells in NOD/SCID mice. Ann N Y Acad Sci. 938:2001;9-17.
8. Peschle C., Botta R., Muller R., Valtieri M., Ziegler B.L. Purification and functional assay of pluripotent hematopoietic stem cells. Rev Clin Exp Hematol. 5:2001;3-14.
9. null mice: An immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol. 164:2000;2496-2507.
10. Shultz L.D., Schweitzer P.A., Christianson S.W., et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 154:1995;180-191.
11. + T cell engraftment in β2-microglobulin-deficient NOD-scid mice. J Immunol. 158:1997;3578-3586.
12. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity. 15:2001;363-374.
13. Brown M.G., Scalzo A.A., Matsumoto K., Yokoyama W.M. The natural killer gene complex: A genetic basis for understanding natural killer cell function and innate immunity. Immunol Rev. 155:1997;53-65.
14. Glimm H., Eisterer W., Lee K., et al. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobulin-null mice. J Clin Invest. 107:2001;199-206.
15. Robson S.C., Esch J.S.A. II, Bach F.H. Factors in xenograft rejection. Ann N Y Acad Sci. 875:1999;261-276.
16. Yoshino H., Ueda T., Kawahata M., et al. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice. Bone Marrow Transplant. 26:2000;1211-1216.
17. Bennett M., Taylor P.A., Austin M., et al. Cytokine and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts: influence of mouse colony environment. Int Immunol. 10:1998;785-790.
18. Santini S.M., Spada M., Parlato S., et al. Treatment of severe combined immunodeficiency mice with anti-murine granulocyte monoclonal antibody improves human leukocyte xenotransplantation. Transplantation. 65:1998;416-420.
19. Terpstra W., Leenen P.J., van den Bos C., et al. Facilitated engraftment of human hematopoietic cells in severe combined immunodeficient mice following a single injection of Cl2MDP liposomes. Leukemia. 11:1997;1049-1054.
20. Fraser C.C., Chen B.P., Webb S., Van Rooijen N., Kraal G. Circulation of human hematopoietic cells in severe combined immunodeficient mice after Cl2MDP-liposome-mediated macrophage depletion. Blood. 86:1995;183-192.
21. Tanaka T., Tsudo M., Karasuyama H., et al. A novel monoclonal antibody against murine IL-2 receptor β-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J Immunol. 147:1991;2222-2228.
22. Ballen K.K., Valinski H., Greiner D., et al. Variables to predict engraftment of umbilical cord blood into immunodeficient mice: usefulness of the non-obese diabetic-severe combined immunodeficient assay. Br J Haematol. 114:2001;211-218.
23. Lowry P.A., Shultz L.D., Greiner D.L., et al. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice following irradiation or multiple day injections into unirradiated recipients. Biol Blood Marrow Transplant. 2:1996;15-23.
24. Tournoy K.G., Depraetere S., Meuleman P., Leroux-Roels B., Pauwels R.A. Murine IL-2 receptor β chain blockade improves human leukocyte engraftment in SCID mice. Eur J Immunol. 28:1998;3221-3230.
25. Glantz S.A. Primer of biostatistics. 1981;McGraw-Hill, New York. p. 352.
26. Siegel S. Nonparametric statistics. 1956;McGraw-Hill, New York. p 1-239.
27. Kagi D., Ledermann B., Burki K., et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:1994;31-37.
28. Young J.D., Liu C.C., Persechini P.M., Cohn Z.A. Perforin-dependent and -independent pathways of cytotoxicity mediated by lymphocytes. Immunol Rev. 103:1988;161-202.
29. Lowin B., Beermann F., Schmidt A., Tschopp J. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci U S A. 91:1994;11571-11575.
30. Tanaka T., Kitamura F., Nagasaka Y., Kuida K., Suqa H., Miyasaka M. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor β-chain monoclonal antibody in mice. J Exp Med. 178:1993;1103-1107.
31. Poulton L.D., Smyth M.J., Hawke C.G., et al. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int Immunol. 13:2001;887-896.
32. Ehl S., Nuesch R., Tanaka T., Myasaka M., Hengartner H., Zinkernagel R. A comparison of efficacy and specificity of three NK depleting antibodies. J Immunol Methods. 199:1996;149-153.
33. Serreze D.V., Gaedeke J.W., Leiter E.H. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: Defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci U S A. 90:1993;9625-9629.
34. Serreze D.V., Gaskins H.R., Leiter E.H. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol. 150:1993;2534-2543.